Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (297)
ARTG (244)
Prescription medicine registration (23)

Date

2026 (2)
2025 (18)
2024 (49)
2023 (48)
2022 (222)
2021 (8)
2020 (33)
2019 (21)
2018 (32)
2017 (11)
2016 (10)
2014 (27)
2013 (14)
2012 (2)
2011 (16)
2010 (19)
2009 (1)
2008 (21)
2007 (5)
2001 (1)
1991 (4)

Search

Sponsor content

564 result(s) found, displaying 271 to 280

ESCITALOPRAM GENERICHEALTH escitalopram (as oxalate) 5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ESCITALOPRAM-MPPL escitalopram (as oxalate) 5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ESCITALOPRAM-MPPL escitalopram (as oxalate) 5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ESCITALOPRAM-LUPIN escitalopram (as oxalate) 5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
ESCITALOPRAM-LUPIN escitalopram (as oxalate) 5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
APOTEX-CEPHALEXIN cefalexin (as monohydrate) 500 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
APOTEX-CEPHALEXIN cefalexin (as monohydrate) 250 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL AND INDAPAMIDE-BW 4/1.25 mg TABLETS perindopril erbumine 4mg and indapamide hemihydrate1.25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
CEPHATRUST 500 cefalexin monohydrate 500 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
CEPHATRUST 250 cefalexin monohydrate 250 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited

Pages

First page
Previous page
…
Page 24
Page 25
Page 26
Page 27
Current page 28
Page 29
Page 30
Page 31
Page 32
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.